Clinical & experimental ophthalmology
-
Clin. Experiment. Ophthalmol. · Nov 2011
Comparative StudyGeldanamycin is effective in the treatment of herpes simplex virus epithelial keratitis in a rabbit model.
To evaluate the efficacy of geldanamycin eye drops against herpes simplex virus epithelial keratitis in a rabbit model. ⋯ Geldanamycin is a promising treatment option against herpes simplex virus type 1 epithelial keratitis. Geldanamycin (10 µg/mL) is better than acyclovir and geldanamycin (5 µg/mL) in the rabbit model. The optimal concentration of this drug in human is still to be determined.
-
Clin. Experiment. Ophthalmol. · Nov 2011
Use of a novel haemostatic agent: ankaferd blood stopper in conjunctival incisions.
To investigate the haemostatic efficacy and histopathological effects of a new haemostatic agent, ankaferd blood stopper, in a rat conjunctival incision model. ⋯ Given the ease of use and lack of histopathological side-effects in the conjunctival incision model, ankaferd blood stopper is promising for use in ophthalmic surgery. Ankaferd blood stopper is a potent haemostatic agent. Its use in ophthalmic surgery should be investigated further in a larger cohort of patients and tested in clinical and experimental models.
-
Clin. Experiment. Ophthalmol. · Sep 2011
Multicenter StudyEye health service access and utilization in the National Indigenous Eye Health Survey.
To determine access to and utilization of eye health services for indigenous Australians. ⋯ Eye health services for indigenous Australians need to be provided in culturally appropriate facilities with clear links to the indigenous community to optimize access to care and reduce the prevalence of vision impairment. The adequate provision of accessible eye care services is an important component in 'closing the gap' in vision loss for indigenous Australians.
-
Clin. Experiment. Ophthalmol. · Sep 2011
Vogt-Koyanagi-Harada disease presenting as acute angle closure glaucoma at onset.
To investigate the clinical features of Vogt-Koyanagi-Harada (VKH) disease presenting as acute angle closure glaucoma at onset. ⋯ VKH disease presenting with a bilateral increased IOP mostly occurs in older women. The strikingly decreased visual acuity associated with mild to moderate increased IOP is a clue to the diagnosis. The increased IOP responded well to corticosteroids but not to anti-glaucoma treatment.